Abstract:Objective: To analyze the clinical and genetic features, as well as the treatment outcomes of two boys with nephrogenic syndrome of inappropriate antidiuresis (NSIAD) caused by gain-of-function mutations in the V2 vasopressin receptor gene (AVPR2). Methods: The clinical manifestations, genetic testing, therapeutic interventions and the outcomes of two boys with NSIAD hospitalized in the Department of Endocrinology, Beijing Children's Hospital in April 2019 were reported. A literature search with "Nephrogenic syndrome of inappropriate antidiuresis" and "AVPR2 gene" as keywords was conducted at the China national knowledge infrastructure (CNKI), the Wanfang Data Knowledge Service Platform, PubMed and Springer Link up to May 2020. Relevant published articles were reviewed. Results: The two cases presented with chronic and severe hyponatremia with hypo-osmolality, inappropriately elevated urinary osmolality and urinary sodium levels. The onset age was 5.25-years and 2 months respectively. AVPR2 sequencing revealed a previously described hemizygous activating mutation (c.409C>T, p.R137C) in both of boys, each inherited the variant from their mother. Patient 1 limited fluid intake by himself in his daily life, intravenous and oral sodium supplementations showed no significant increase of serum sodium level. Oral furosemide increased the serum sodium level and maintained it within normal range. The serum sodium and potassium levels were in the normal range during the 1-year follow-up period with oral furosemide. The serum sodium level of Patient 2 increased with restricting fluid intake and with salt supplementation. However, after he experienced respiratory infection, the plasma sodium level decreased. Subsequently, oral anti-infection medicine and furosemide were applied. The serum sodium level increased two days later and remained at a normal range afterwards. The boy was 1 year old with normal growth. He stopped taking furosemide after 4 months while taking 1 gram of salt per day, the blood sodium level maintained at normal range. Literature search identified no reports in Chinese journals, whereas 50 publications were found in English journals. A total of 30 NSIAD probands were reported and 16 of those (53%) had childhood onset, most presented with seizures. The majority had a hotspot change at the nucleotide position of 409 in AVPR2. Nine cases had an amino acid change as R137C and five cases as R137L. Fluid restriction and oral urea intake were main treatment options, no report so far was found with oral furosemide treatment. Conclusions: NSIAD presented with hyponatremia without any other specific presentations. Genetic testing for variants in AVPR2 is helpful for early diagnosis and timely treatment. The first two cases of oral furosemide treatment were reported by the article which helped to maintain a normal serum sodium level after limiting fluid intake and supplementing sodium which showed limited effect.

A Missense Mutation in the Arginine‐vasopressin Neurophysin‐ii Gene Causes Autosomal Dominant Neurohypophyseal Diabetes Insipidus in a Chinese Family

Autosomal Dominant Familial Neurohypophyseal Diabetes Insipidus Caused by a Novel Nonsense Mutation in AVP-NPII Gene.

[Analysis of AVPR2 Variant in a Neonate with Congenital Nephrogenic Diabetes Insipidus].

Autosomal dominant neurohypophyseal diabetes insipidus with linkage to chromosome 20p13 but without mutations in the AVP-NPII gene.

Linkage and Mutation Analysis of a Family with Autosomal Dominant Neurohypophyseal Diabetes Insipidus

A Novel Avpr2 Missense Mutation in A Chinese Boy with Severe Inherited Nephrogenic Diabetes Insipidus

Deletion of the V2 Vasopressin Receptor Gene in Two Chinese Patients with Nephrogenic Diabetes Insipidus

Forty-One Individuals With Mutations in the AVP-NPII Gene Associated With Familial Neurohypophyseal Diabetes Insipidus

Congenital nephrogenic diabetes insipidus arginine vasopressin receptor 2 gene mutation at new site: A case report

Genetic analysis of nephrogenic diabetes insipidus patients: A study on the Iranian population

Genetic Analysis of A Congenital Nephrogenic Diabetes Insipidus Pedigree

Mutation Analysis of AVPR2 and AQP2 Gene in Chinese Patients with Congenital Nephrogenic Diabetes Insipidus

Nephrogenic diabetes insipidus results from a novel in-frame deletion of AVPR2 gene in monozygotic-twin boys and their mother and grandmother

Integrating Population Variants and Protein Structural Analysis to Improve Clinical Genetic Diagnosis and Treatment in Nephrogenic Diabetes Insipidus

47 in a pedigree with autosomal dominant neurohypophyseal diabetes insipidus

The ND4 G11696A Mutation May Influence the Phenotypic Manifestation of the Deafness-Associated 12S Rrna A1555G Mutation in a Four-Generation Chinese Family.

Diagnosis and Follow-Up of 2 Cases of Pediatric Nephrogenic Syndrome of Inappropriate Antidiuresis Resulting from Activating Mutation in AVPR2 and Literature Review

Novel Large Deletion in AVPR2 Gene Causing Copy Number Variation in a Patient with X-linked Nephrogenic Diabetes Insipidus.

Genetic Diagnosis for a Pedigree Affected with Hereditary Nephrogenic Diabetes Insipidus

Integrating population variation and protein structural analysis to improve the clinical genetic diagnosis and treatment in children with congenital nephrogenic diabetes insipidus

Autosomal dominant nephrogenic diabetes insipidus in one family caused by a novel AQP2 mutation